WFL 0.00% 0.3¢ wellfully limited

Ann: Clinical Trial for BodyGuard Technology, page-58

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,636 Posts.
    lightbulb Created with Sketch. 1021
    And before anybody tries to counter by stating that this new trial for NSAID/Nurofen is a human clinical trial (in vivo), OBJ did conduct a few human clinical trials for various molecules over the years, including this one for Tetracaine (local anaesthetic) via Dermaportation again (with 5 subjects):



    tet1.JPG
    http://www.asx.com.au/asxpdf/20060419/pdf/3wc70bhcfcn25.pdf



    Tet2.JPG
    http://www.asx.com.au/asxpdf/20061207/pdf/31008146gp2s5q.pdf



    I'm really beginning to question and wonder exactly how good Dermaportation is, especially given the fact that COTY are taking their sweet, sweet, sweet time to seal a deal.

    Jeff Edwards was given a substantial portion of shares in OBJ in 2004 when OBJ was re-born and it was all pretty much at the time for Dermaportation, via International Scientific Pty Ltd:



    Jef2.JPG



    Jeff.JPG


    Jef3.JPG
    http://www.asx.com.au/asxpdf/20040824/pdf/3mkwbrbxwybns.pdf



    I'm not 100% sure whether they went on to claim the A & B Class Shares back then for a 5 person trial or whether they met them in relation to one of the other larger trials (certainly not C Class). Need somebody not too time poor to scrutinise all the announcements.

    So to me, it looks like after all the various Dermaportation trials (there have been a few), not one has led to a single cent for Shareholders...yet. Dermaportation is OBJ's foundation tech platform to which OBJ was born.

    Although Directors have participated very mildly imo in some of the Capital Raises over the years and I tried to politely have this discussion with Abdm, where he decided not to reply as to the exact average price these guys have paid over the years across all the freebies, performance shares etc; I guess it's just too hard to work out among the plethora of announcements back then. Although I definately have strong suspicions already it is a very, very low low average.

    My biggest concern here is that Dermaportation since inception is yet to monetised after 13 years ie the foundation on which this company was created is yet to earn a cent....

    Alot of other progress has occurred outside of Dermaportation, so I really do hope that this new Pharmaceutical trial for Nurofen is NOT utilsing The Dermaportation platform in any fashion whatsoever.
 
watchlist Created with Sketch. Add WFL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.